Summary of PHARMAC decisions
EFFECTIVE 1 April 2021
On this page
New listings
- Mesalazine (Pentasa) suppos 1 g, 28 pack
- Mexiletine hydrochloride (Teva) tab 150 mg and 250 mg – S29 and wastage claimable
- Aqueous cream (Medco) crm, 500 g
- Tenoxicam (Tilcotil) tab 20 mg
- Moclobemide (Aurorix) tab 150 mg
- Atomoxetine (Strattera) cap 10 mg and 40 mg
- Mepolizumab (Nucala) inj 100 mg prefilled syringe – Special Authority
– Retail pharmacy - Loratadine (Haylor syrup) oral liq 1 mg per ml, 100 ml
- Latanoprost with timolol (Arrow - Lattim) eye drops 0.005% with timolol 0.5%, 2.5 ml OP
- Pharmacy services (BSF Bisoprolol Mylan and BSF Darunavir Mylan) brand switch fee – may only be claimed once per patient
- Diabetic oral feed 1kcal/ml (Nutren Diabetes) liquid (vanilla), 200 ml OP – Special Authority – Hospital pharmacy [HP3]
Changes to restrictions
- Omeprazole cap 20 mg (Omeprazole Actavis 20) and cap 40 mg (Omeprazole Actavis 40) – stat dispensing removed
- SGLT2 inhibitors – amended therapeutic group name and addition of Special Authority
- Empagliflozin (Jardiance) tab 10 mg and 25 mg – amended Special Authority criteria
- Empagliflozin with metformin hydrochloride (Jardiamet) tab 5 mg with 500 mg and 1,000 mg metformin hydrochloride and tab 12.5 mg with 500 mg and 1,000 mg metformin hydrochloride – amended Special Authority criteria
- Potassium chloride (Juno) inj 75 mg per ml, 10 ml – S29 and wastage removed
- Quinapril tab 5 mg (Arrow-Quinapril 5), tab 10 mg (Arrow-Quinapril 10) and tab 20 mg (Arrow-Quinapril 20) – stat dispensing removed
- Bisoprolol fumarate (Bisoprolol Mylan) tab 2.5 mg, 5 mg and 10 mg – addition of brand switch fee
- Zoledronic acid (Zoledronic Acid Mylan) inj 4 mg per 5 ml, vial – amended Special Authority criteria
- Somatropin (Omnitrope) inj 5 mg, 10 mg and 15 mg cartridge – amended Special Authority criteria
- Darunavir (Darunavir Mylan) tab 400 mg and 600 mg – addition of brand switch fee
- Pegylated interferon alfa-2a (Pegasys) inj 180 mcg prefilled syringe
– amended Special Authority criteria - Sertraline (Setrona, Setrona AU and Arrow-Sertraline) tab 50 mg and 100 mg – reinstate stat dispensing
- Lapatinib ditosylate (Tykerb) tab 250 mg – amended Special Authority criteria and addition of note
Decreased subsidy
- Ethinyloestradiol with desogestrel (Mercilon 28) tab 20 mcg with desogestrel 150 mcg and 7 inert tab
- Bendamustine hydrochloride inj 25 mg and 100 mg vial (Ribomustine) and inj 1 mg for ECP (Baxter)
- Aciclovir (ViruPOS) eye oint 3%, 4.5 OP
- Brinzolamide (Azopt) eye drops 1%, 5 ml OP